Antimicrobial-resistant nocardia isolates, United States, 1995-2004.
We conducted a 10-year retrospective evaluation of the epidemiology and identification of Nocardia isolates submitted to the Centers for Disease Control and Prevention for antimicrobial susceptibility testing. The species most commonly identified were N. nova (28%), N. brasiliensis (14%), and N. farcinica (14%). Of 765 isolates submitted, 61% were resistant to sulfamethoxazole and 42% were resistant to trimethoprim-sulfamethoxazole.
Bacterial Zoonoses Branch, Division of Foodborne, Bacterial, and Mycotic Diseases, National Center for Zoonotic, Vector-Borne, and Enteric Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA. Kristin.uhde@sanofipasteur.com
Kristin Broome
KB
Uhde
Sonal
S
Pathak
Isaac
I
McCullum
Deanna P
DP
Jannat-Khah
Sean V
SV
Shadomy
Clare A
CA
Dykewicz
Thomas A
TA
Clark
Theresa L
TL
Smith
June M
JM
Brown
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002648:Child; D002675:Child, Preschool; D024881:Drug Resistance, Bacterial; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D008875:Middle Aged; D009615:Nocardia / Q000187:drug effects* / Q000302:isolation & purification; D009617:Nocardia Infections / Q000453:epidemiology* / Q000382:microbiology*; D012189:Retrospective Studies; D014481:United States / Q000453:epidemiology; D055815:Young Adult
D000900:Anti-Bacterial Agents